Simple breath test could predict best IBS treatment
NCT ID NCT03729271
Summary
This study aimed to see if a simple breath test could help doctors predict which patients with diarrhea-predominant Irritable Bowel Syndrome (IBS-D) would respond well to the antibiotic rifaximin. About 148 adults with IBS-D took the breath test, received a 14-day course of rifaximin, and tracked their symptoms. The goal was to find a better way to match patients with a treatment that works for them, potentially reducing trial and error.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IRRITABLE BOWEL SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
Conditions
Explore the condition pages connected to this study.